{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:38:00Z","timestamp":1778503080200,"version":"3.51.4"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0199229","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T17:28:14Z","timestamp":1529429294000},"page":"e0199229","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Adverse events after vaccination among HIV-positive persons, 1990\u20132016"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5897-8031","authenticated-orcid":true,"given":"John R.","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-3907","authenticated-orcid":true,"given":"Carmen","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige W.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria V.","family":"Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"ref1","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report, 2015; vol. 27. http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html<\/ext-link>. Published November 2016."},{"key":"ref2","unstructured":"Centers for Disease Control and Prevention [updated February 13, 2017]. Available from: https:\/\/www.cdc.gov\/winnablebattles\/hiv\/index.html<\/ext-link>."},{"key":"ref3","unstructured":"Centers for Disease Control and Prevention. Opportunistic Infections: U.S. Department of Health and Human Services; 2016 [updated Feb 27, 2017]. Available from: https:\/\/www.cdc.gov\/hiv\/basics\/livingwithhiv\/opportunisticinfections.html<\/ext-link>."},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/jmv.20684","article-title":"An outbreak of influenza in a residential drug-rehabilitation community","volume":"78","author":"A Boschini","year":"2006","journal-title":"J Med Virol"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/cid\/ciu558","article-title":"Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users","volume":"59","author":"ZB Harboe","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archinte.161.3.441","article-title":"Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome","volume":"161","author":"JC Lin","year":"2001","journal-title":"Arch Intern Med"},{"key":"ref7","article-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases","year":"2015"},{"key":"ref8","unstructured":"Centers for Disease Control and Prevention. HIV Infection and Adult Vaccination 2017 [updated Feb 27, 2017]. Available from: https:\/\/www.cdc.gov\/vaccines\/adults\/rec-vac\/health-conditions\/hiv.html<\/ext-link>."},{"key":"ref9","unstructured":"National Institute of Health. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents 2015 [updated Feb 27, 2017]. Available from: https:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultOITablesOnly.pdf<\/ext-link>."},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/QCO.0b013e328334fec4","article-title":"Immunization for HIV-positive individuals","volume":"23","author":"AM Geretti","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-2796.2008.02043.x","article-title":"Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?","volume":"265","author":"A Boasso","year":"2009","journal-title":"J Intern Med"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1513\/pats.200507-077JS","article-title":"The immunocompromised host: HIV infection","volume":"2","author":"JM Beck","year":"2005","journal-title":"Proc Am Thorac Soc"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAI.0b013e3181632cda","article-title":"Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy","volume":"48","author":"A Vigano","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/ijsa.2009.009126","article-title":"Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations","volume":"20","author":"HN Kim","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"31\u201332","key":"ref15","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1016\/S0264-410X(02)00357-2","article-title":"Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users","volume":"20","author":"A Amendola","year":"2002","journal-title":"Vaccine"},{"issue":"36","key":"ref16","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","article-title":"Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)","volume":"33","author":"TT Shimabukuro","year":"2015","journal-title":"Vaccine"},{"key":"ref17","unstructured":"MedDRA [August 2, 2016]. Available from: www.meddra.com<\/ext-link>."},{"key":"ref18","unstructured":"U.S. Food and Drug Administration, 2015 [August 2, 2016]. Available from: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=310.305<\/ext-link>."},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.15585\/mmwr.mm6504a5","article-title":"Advisory Committee on Immunization Practices AAIWG. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older\u2014United States, 2016","volume":"65","author":"DK Kim","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.15585\/mmwr.mm6504a4","article-title":"Advisory Committee on Immunization Practices. Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years\u2014United States, 2016","volume":"65","author":"CL Robinson","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref21"},{"key":"ref22","first-page":"71","article-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","year":"2016"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"U.S. Department of Health and Human Services. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children 2013 [updated November 6, 2013]. Available from: https:\/\/aidsinfo.nih.gov\/guidelines\/html\/5\/pediatric-opportunistic-infection\/431\/figure-1\u2014recommended-immunization-schedule-for-hiv-infected-children-aged-0-6-years\u2014united-states\u20142013<\/ext-link>.","DOI":"10.1097\/01.inf.0000437892.16446.1c"},{"issue":"Suppl 1","key":"ref24","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/clinids\/21.Supplement_1.S134","article-title":"Quality standard for the enumeration of CD4+ lymphocytes in infants and children exposed to or infected with human immunodeficiency virus","volume":"21","author":"CM Wilfert","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"RR-14","key":"ref25","first-page":"1","article-title":"Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings","volume":"55","author":"BM Branson","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.15585\/mmwr.mm6605e2","article-title":"Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older\u2014United States, 2017","volume":"66","author":"DK Kim","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.15585\/mmwr.mm6605e1","article-title":"Advisory Committee on Immunization Practices Child\/Adolescent Immunization Workgroup. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger\u2014United States, 2017","volume":"66","author":"CL Robinson","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref28","unstructured":"Centers for Disease Control and Prevention. Vaccine Information Statements (VISs) 2016 [updated December 2, 2016March 8, 2017]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/current-vis.html<\/ext-link>."},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1590\/S0037-86822011000600026","article-title":"Acute meningoencephalomyelitis due to varicella-zoster virus in an AIDS patient: report of a case and review of the literature","volume":"44","author":"M Corti","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/00365540600561785","article-title":"Fulminant varicella hepatitis in a human immunodeficiency virus infected patient: case report and review of the literature","volume":"38","author":"C Lechiche","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.idcr.2016.09.010","article-title":"No light at the end of the tunnel \u2026 an unfortunate case of varicella-associated progressive outer retinal necrosis in a patient with neglected HIV infection","volume":"6","author":"RE Winsett","year":"2016","journal-title":"IDCases"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"E39","DOI":"10.1542\/peds.108.2.e39","article-title":"Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child","volume":"108","author":"JM Kramer","year":"2001","journal-title":"Pediatrics"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcv.2013.10.027","article-title":"Disseminated vaccine-strain varicella as initial presentation of the acquired immunodeficiency syndrome: a case report and review of the literature","volume":"59","author":"RC Maves","year":"2014","journal-title":"J Clin Virol"},{"issue":"14","key":"ref34","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.vaccine.2005.12.021","article-title":"Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study","volume":"24","author":"V Falco","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/165.3.553","article-title":"Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine","volume":"165","author":"MC Rodriguez-Barradas","year":"1992","journal-title":"J Infect Dis"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/01.aids.0000206507.54901.84","article-title":"Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990\u20132003","volume":"20","author":"PM Barry","year":"2006","journal-title":"AIDS"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/319218","article-title":"Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination","volume":"32","author":"MS Dworkin","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00006454-199403000-00008","article-title":"Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children","volume":"13","author":"EG Chadwick","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"ref39","first-page":"1","article-title":"Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore","author":"YF Lau","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"LG Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"LG Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"27","key":"ref42","first-page":"577","article-title":"Intussusception among recipients of rotavirus vaccine\u2014United States, 1998\u20131999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"43","key":"ref43","first-page":"1007","article-title":"Withdrawal of rotavirus vaccine recommendation","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref44","unstructured":"Lowes R. ACIP Narrowly Recommends Shingrix for Shingles Over Zostavax: Medscape Medical News; 2017. Available from: https:\/\/www.medscape.com\/viewarticle\/887626<\/ext-link>."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0199229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T23:35:51Z","timestamp":1604446551000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0199229"}},"subtitle":[],"editor":[{"given":"Nigel William","family":"Crawford","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0199229","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]}}}